Allergan Sues Drugmakers Over Linzess Generics

Law360, New York (December 1, 2016, 9:11 PM EST) -- Allergan USA Inc. hit four generic-drug makers with a suit Wednesday in Delaware federal court accusing them of jumping the gun on producing a generic version of its irritable bowel syndrome treatment Linzess.

In the suit filed on Wednesday, Allergan said Teva Pharmaceuticals USA Inc., Mylan Pharmaceuticals Inc., Sandoz Inc. and Aurobindo Pharma Ltd. rushed to apply to make generic Linzess capsules, which are prescribed to relieve symptoms of irritable bowel syndrome and chronic constipation, before the drug’s patents expire. 

“Each of the defendants has participated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.